<DOC>
	<DOCNO>NCT02045862</DOCNO>
	<brief_summary>The purpose study examine well combination two medicine ( solifenacin succinate mirabegron ) work compare medicine alone treatment bladder problem , safe long term use .</brief_summary>
	<brief_title>A Multinational Study Comparing Long-term Efficacy Safety Two Medicines , Solifenacin Succinate Mirabegron Taken Together , Separately , Mock Treatment ( Placebo ) Subjects With Symptoms Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Bladder Diseases</mesh_term>
	<mesh_term>Urologic Diseases</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Main Inclusion Screening ( Visit 1 ) : Subject complete study 178CL101 study 905EC012 ( This inclusion criterion longer apply recruitment study 178CL101 study 905EC012 complete . In case subject symptom `` wet '' OAB ( urinary frequency urgency incontinence ) least 3 month ) ; Subject willing able complete micturition diary questionnaire correctly able measure his/her vital sign home stipulate time point , use device provide study personnel , adequately record reading ; Main Inclusion Randomization ( Visit 2 ) : Subject micturition frequency average â‰¥ 8 time per 24hour period last 7 day micturition diary period ( incontinence episode count micturition ) . Subject experience least 3 incontinence episode last 7 day micturition diary period . Subject experienced average least 1 urgency episode ( grade 3 4 Patient Perception Intensity Urgency Scale [ PPIUS ] ) per 24hour period 7day micturition diary period . Main Exclusion Screening ( Visit 1 ) : Subject clinically significant bladder outflow obstruction risk urinary retention ; Subject significant PVR volume ( &gt; 150 mL ) ; Subject significant stress incontinence mixed stress/urgency incontinence stress predominant factor ; Subject indwell catheter practice intermittent selfcatheterization ; Subject evidence UTI ( urine culture contain &gt; 100,000 cfu/mL ) , chronic inflammation interstitial cystitis , bladder stone , previous pelvic radiation therapy previous current malignant disease pelvic organ ; Subject intravesical treatment past 12 month e.g. , botulinum toxin , resiniferatoxin , capsaicin ; Main Exclusion Randomization ( Visit 2 ) : Subject evidence UTI ( urine culture contain &gt; 100,000 cfu/mL ) assess Screening visit ( V1 ) sample . The subject rescreened successful treatment UTI ( confirm dipstick negative nitrite ) . Subject average total daily urine volume &gt; 3000 mL record micturition diary period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Solifenacin Succinate</keyword>
	<keyword>Mirabegron</keyword>
	<keyword>Urinary Incontinence</keyword>
	<keyword>Combination Therapy</keyword>
	<keyword>Urgency</keyword>
	<keyword>Nocturia</keyword>
	<keyword>Overactive Bladder</keyword>
</DOC>